Radioimmunotherapy: Designer molecules to potentiate effective therapy
Author:
- 30 April 2000
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 10 (2) , 139-155
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- ‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerizationProtein Engineering, Design and Selection, 1996
- Bifunctional Antibodies for RadioimmunotherapyHybridoma, 1995
- Current status of radioimmunotherapyNuclear Medicine and Biology, 1994
- Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variantCancer Immunology, Immunotherapy, 1992
- Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coliBiochemistry, 1991
- Comparative Pharmacokinetic Properties of Murine Monoclonal Antibody A7 Modified with Neocarzinostatin, Dextran and Polyethylene GlycolJapanese Journal of Cancer Research, 1991
- Production of antibodies in transgenic plantsNature, 1989
- Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coliNature, 1989
- Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: Histological and autoradiographic study of effects on tumors and normal organsEuropean Journal of Cancer and Clinical Oncology, 1987
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986